Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Pelizzaro F, Trevisani F, Simeon V, Vitale A, Cillo U, Piscaglia F, Missale G, Sangiovanni A, Foschi FG, Cabibbo G, Caturelli E, Di Marco M, Azzaroli F, Brunetto MR, Raimondo G, Vidili G, Guarino M, Gasbarrini A, Campani C, Svegliati-Baroni G, Giannini EG, Mega A, Masotto A, Rapaccini GL, Magalotti D, Sacco R, Nardone G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Pelizzaro F, et al. Among authors: giannini eg. Liver Int. 2023 Dec;43(12):2762-2775. doi: 10.1111/liv.15719. Epub 2023 Sep 27. Liver Int. 2023. PMID: 37753540
Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R. Giannini E, et al. Liver Int. 2004 Oct;24(5):465-70. doi: 10.1111/j.1478-3231.2004.0949.x. Liver Int. 2004. PMID: 15482344
Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.
Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M, Borzio F, Caturelli E; Italian Liver Cancer (ITA.LI.CA.) Group. Giannini EG, et al. Clin Gastroenterol Hepatol. 2006 Nov;4(11):1378-84. doi: 10.1016/j.cgh.2006.08.011. Epub 2006 Oct 23. Clin Gastroenterol Hepatol. 2006. PMID: 17059899
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M; Italian Liver Cancer (ITA.LI.CA) Group. Trevisani F, et al. Among authors: giannini eg. Am J Gastroenterol. 2007 May;102(5):1022-31. doi: 10.1111/j.1572-0241.2007.01100.x. Epub 2007 Feb 21. Am J Gastroenterol. 2007. PMID: 17313497
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M; Italian Liver Cancer Group. Trevisani F, et al. Among authors: giannini eg. Am J Gastroenterol. 2007 Nov;102(11):2448-57; quiz 2458. doi: 10.1111/j.1572-0241.2007.01395.x. Epub 2007 Jul 7. Am J Gastroenterol. 2007. PMID: 17617210
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S; Italian Association of the Study of the Liver Disease (AISF). Stroffolini T, et al. Am J Gastroenterol. 2008 Aug;103(8):1966-72. doi: 10.1111/j.1572-0241.2008.01912.x. Epub 2008 Jul 12. Am J Gastroenterol. 2008. PMID: 18637087
Hepatocellular carcinoma in patients with cryptogenic cirrhosis.
Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M; Italian Liver Cancer (ITALICA) Group. Giannini EG, et al. Clin Gastroenterol Hepatol. 2009 May;7(5):580-5. doi: 10.1016/j.cgh.2009.01.001. Clin Gastroenterol Hepatol. 2009. PMID: 19418607
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer group. Farinati F, et al. Among authors: giannini eg. Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1212-8. doi: 10.1097/MEG.0b013e32831a86f8. Eur J Gastroenterol Hepatol. 2009. PMID: 19465859
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Giannini EG, Bodini G, Corbo M, Savarino V, Risso D, Di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; ITALIAN LIVER CANCER (ITA.LI.CA.) GROUP. Giannini EG, et al. Aliment Pharmacol Ther. 2010 Feb 15;31(4):493-501. doi: 10.1111/j.1365-2036.2009.04198.x. Epub 2009 Nov 14. Aliment Pharmacol Ther. 2010. PMID: 19912152 Free article.
320 results